---
title: "DC 6333 - Nontyphoid salmonella infections"
diagnostic_code: "6333"
body_system: "Infectious Diseases, Immune Disorders and Nutritional Deficiencies"
cfr_section: "§ 4.88b"
canonical: "https://veteranai.co/va-rating-schedule/infectious-and-immune/6333-nontyphoid-salmonella-infections"
source: "https://www.ecfr.gov/current/title-38/section-4.88b"
updated: "2026-07-21T20:32:10.402632Z"
---

# DC 6333 - Nontyphoid salmonella infections

Rated under § 4.88b. Body system: Infectious Diseases, Immune Disorders and Nutritional Deficiencies.

General Rating Formula for Infectious Diseases

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | For active disease |
| 100% | As active disease |
| 100% | As active disease |
| 100% | As active disease |
| 100% | As active disease |
| 100% | Marked mental changes, moist dermatitis, inability to retain adequate nourishment, exhaustion, and cachexia |
| 60% | With all of the symptoms listed below, plus mental symptoms and impaired bodily vigor |
| 40% | With stomatitis, diarrhea, and symmetrical dermatitis |
| 20% | With stomatitis, or achlorhydria, or diarrhea |
| 10% | Confirmed diagnosis with nonspecific symptoms such as: decreased appetite, weight loss, abdominal discomfort, weakness, inability to concentrate and irritability |
| 100% | With congestive heart failure, anasarca, or Wernicke-Korsakoff syndrome |
| 60% | With cardiomegaly, or; with peripheral neuropathy with footdrop or atrophy of thigh or calf muscles |
| 30% | With peripheral neuropathy with absent knee or ankle jerks and loss of sensation, or; with symptoms such as weakness, fatigue, anorexia, dizziness, heaviness and stiffness of legs, headache or sleep disturbance |
| 100% | Marked mental changes, moist dermatitis, inability to retain adequate nourishment, exhaustion, and cachexia |
| 60% | With all of the symptoms listed below, plus mental symptoms and impaired bodily vigor |
| 40% | With stomatitis, diarrhea, and symmetrical dermatitis |
| 20% | With stomatitis, or achlorhydria, or diarrhea |
| 10% | Confirmed diagnosis with nonspecific symptoms such as: decreased appetite, weight loss, abdominal discomfort, weakness, inability to concentrate and irritability |
| 100% | As active disease |
| 0% | As acute or asymptomatic chronic disease |
| 100% | Not to be combined with ratings under DC 7809 Acute, with frequent exacerbations, producing severe impairment of health |
| 60% | Exacerbations lasting a week or more, 2 or 3 times per year |
| 10% | Exacerbations once or twice a year or symptomatic during the past 2 years |
| 100% | AIDS with recurrent opportunistic infections (see Note 3) or with secondary diseases afflicting multiple body systems; HIV-related illness with debility and progressive weight loss |
| 60% | Refractory constitutional symptoms, diarrhea, and pathological weight loss; or minimum rating following development of AIDS-related opportunistic infection or neoplasm |
| 30% | Recurrent constitutional symptoms, intermittent diarrhea, and use of approved medication(s); or minimum rating with T4 cell count less than 200 |
| 10% | Following development of HIV-related constitutional symptoms; T4 cell count between 200 and 500; use of approved medication(s); or with evidence of depression or memory loss with employment limitations |
| 0% | Asymptomatic, following initial diagnosis of HIV infection, with or without lymphadenopathy or decreased T4 cell count |
| 100% | Which are nearly constant and so severe as to restrict routine daily activities almost completely and which may occasionally preclude self-care |
| 60% | Which are nearly constant and restrict routine daily activities to less than 50 percent of the pre-illness level; or which wax and wane, resulting in periods of incapacitation of at least six weeks total duration per year |
| 40% | Which are nearly constant and restrict routine daily activities from 50 to 75 percent of the pre-illness level; or which wax and wane, resulting in periods of incapacitation of at least four but less than six weeks total duration per year |
| 20% | Which are nearly constant and restrict routine daily activities by less than 25 percent of the pre-illness level; or which wax and wane, resulting in periods of incapacitation of at least two but less than four weeks total duration per year |
| 10% | Which wax and wane but result in periods of incapacitation of at least one but less than two weeks total duration per year; or symptoms controlled by continuous medication |

## Notes

- Note: Rate under the appropriate body system any residual disability of infection, which includes, but is not limited to, reactive arthritis.

# Nontyphoid Salmonella Infections (VA Diagnostic Code 6333)

*Body system: Infectious Diseases, Immune Disorders and Nutritional Deficiencies · 38 CFR § 4.88b · Rated under the General Rating Formula for Infectious Diseases*

## What This Condition Covers

Diagnostic Code 6333 addresses **nontyphoid salmonella infections**. Under the VA's schedule, this condition is evaluated using the General Rating Formula for Infectious Diseases.

An important part of how this code works involves **residual disability** — the lasting effects an infection can leave behind after the active illness has resolved.

> **Note:** Any residual disability of infection is rated under the appropriate body system. This includes, but is not limited to, reactive arthritis.

## Available Rating Levels

The rating schedule provides for the following evaluation levels associated with this condition:

### Active Disease
- **100%** — For active disease.

### Asymptomatic or Chronic Disease
- **0%** — As acute or asymptomatic chronic disease.

## What the VA Looks For

When evaluating this condition, the VA distinguishes between **active disease** and disease that is **acute or asymptomatic chronic**:

- **Active disease** is evaluated at the 100% level.
- **Acute or asymptomatic chronic disease** is evaluated at the 0% level.

Because this code is rated under the General Rating Formula for Infectious Diseases, the VA also considers whether the infection has left any **residual disability**. When residual effects exist — such as reactive arthritis — those are rated separately under the body system that best fits the residual condition.

---

*This information is drawn from the VA rating schedule for Diagnostic Code 6333. It is provided for general educational purposes and describes how the condition is categorized within the rating schedule. It does not predict any individual outcome.*

Source: https://www.ecfr.gov/current/title-38/section-4.88b